Farmers & Merchants Investments Inc’s Moderna MRNA Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.7K	Hold	210	–	–	﹤0.01%	683
2026 Q1	$10.7K	Hold	210	–	–	﹤0.01%	751
2025 Q4	$6.19K	Hold	210	–	–	﹤0.01%	895
2025 Q3	$5.42K	Hold	210	–	–	﹤0.01%	954
2025 Q2	$5.79K	Hold	210	–	–	﹤0.01%	876
2025 Q1	$5.95K	Hold	210	–	–	﹤0.01%	837
2024 Q4	$8.73K	Hold	210	–	–	﹤0.01%	712
2024 Q3	$14K	Hold	210	–	–	﹤0.01%	641
2024 Q2	$24.9K	Hold	210	–	–	﹤0.01%	524
2024 Q1	$22.4K	Buy	210 +195	+1,300%	+$19.7K	﹤0.01%	509
2023 Q4	$1.49K	Sell	15 -6	-29%	-$505	﹤0.01%	1267
2023 Q3	$2.17K	Buy	21 +6	+40%	+$669	﹤0.01%	985
2023 Q2	$1.82K	Hold	15	–	–	﹤0.01%	1125
2023 Q1	$2.3K	Hold	15	–	–	﹤0.01%	967
2022 Q4	$2.69K	Hold	15	–	–	﹤0.01%	935
2022 Q3	$2K	Sell	15 -32	-68%	-$4.86K	﹤0.01%	1023
2022 Q2	$7K	Hold	47	–	–	﹤0.01%	803
2022 Q1	$8K	Sell	47 -9	-16%	-$1.51K	﹤0.01%	810
2021 Q4	$14K	Sell	56 -18	-24%	-$5.26K	﹤0.01%	666
2021 Q3	$28K	Buy	74 +9	+14%	+$3.32K	﹤0.01%	497
2021 Q2	$15K	Hold	65	–	–	﹤0.01%	541
2021 Q1	$9K	Hold	65	–	–	﹤0.01%	653
2020 Q4	$7K	Buy	+65	New	+$6.58K	﹤0.01%	700

Other funds holding MRNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Farmers & Merchants Investments Inc's MRNA Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Moderna (MRNA) position steady in Q2 2026 at 210 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

Farmers & Merchants Investments Inc first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $28K in Q3 2021. 479 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Farmers & Merchants Investments Inc held 210 shares of Moderna worth $14.7K as of Q2 2026.
Farmers & Merchants Investments Inc left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #683 holding.
Farmers & Merchants Investments Inc first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
Farmers & Merchants Investments Inc's Moderna position peaked at $28K in Q3 2021.
479 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.